Performance
Highlights
ReconciliationOF net profit tounitholders distribution
Notes
FY16
S$'000
FY15
S$'000
Net profit for the period attributable to unitholders of the Trust
43,476
37,423
Distribution adjustments:
Impact of non-cash straight-lining
(4,472)
(5,451)
Technology renewal fee
(699)
(694)
Depreciation and amortisation
16,344
13,908
Amortisation of debt arrangement fee
336
607
Trustee-Manager fees payable in units
3,296
3,619
Deferred tax
5,141
6,842
Foreign exchange differences
I
(1,660)
(2,392)
Capital expenditure
II
(1,148)
(944)
Transaction cost capital in nature
III
967
5,494
Unrealised gain on financial asset
2
(246)
Total distributable income attributable to unitholders of the Trust
61,583
58,166
Notes:
I
Included in foreign exchange differences are
(i) adjustments for the distributable income based on the average forward contracted INR/SGD rate against INR/SGD for the translation of the statement of comprehensive
income; (ii) changes in fair value on financial derivatives and; (iii) foreign exchange differences recorded in the statement of comprehensive income.
II This relates to operating cash flow being used to partially fund capital expenditure.
III In FY15, this amount relates to the one-off stamp duty and professional fees incurred in connection to the acquisition of the Mohali Clinical Establishment. These transaction
costs which were treated as capital in nature and were offset with the non-cash gain recognised in connection with the Mohali acquisition. In FY16, the amount relates to
expenses recognised in connection with the potential sale of 51% interest in Fortis Hospotel Limited ("FHTL") which are expected to be deducted against the sale proceeds.
RHT UNIT PRICE AND TRADING VOLUME 1 April 2015 to 31March 2016
RHT UNIT PRICE
(S$)
VOLUME TRADED
(MILLIONS OF UNITS)
1.15
7.0
1.10
6.0
1.05
5.0
1.00
4.0
0.95
3.0
0.90
2.00
0.85
1.00
0.80
0.00
Source: Bloomberg
Volume Traded
RHT Unit Closing Price
004
Religare Health Trust
